StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Oncology — US YoY by Quarter

Oncology — US YoY (%) (%)

QuarterlyAnnual

AstraZeneca Oncology — US YoY: 14.0% in Q2 2026, down 6.0 pts from a year earlier. That is the lowest of the 23 quarters on record here.

Latest, Q2 2026
14.0%
Period ended Jun 30, 2026
Change on a year earlier
-6.0 pts
20.0% in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Oncology | 6,713 | | 15 | | 13 | | 3,163 | | 14 | | 1,522 | | 16 | | 12 | | 1,408 | | 19 | | 14 | | 620 | | 5 | | 10”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Therapy Area Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOncology — US YoY (%) (%)Year on yearSource
Q2 2026Jun 30, 202614.0%-6.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202616.0%+1.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202518.0%-10.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202516.0%-9.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202520.0%+3.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202515.0%-7.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202428.0%+12.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202425.0%+9.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202417.0%-5.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202422.0%-2.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202316.0%-7.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202316.0%-11.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202322.0%-4.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202324.0%+7.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202223.0%-4.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202227.0%+5.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Oncology — US YoY (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-oncology-us-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.